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Abstract: 
The prevalent and long neglected diabetic foot ulcer (DFU) and its related complications 
rank among the most debilitating and costly sequelae of diabetes. Management of the 
DFU is multifaceted and requires constant monitoring from patients, caregivers, and 
healthcare providers.  The alarmingly high rates of recurrence of ulcerations in the 
diabetic foot requires a change in our approach to care and to the vernacular in the 
medical literature. Our efforts should be directed not only on healing of open wounds, 
but also on maximizing ulcer-free days for the patient in diabetic foot remission. The 
increasing development and use of technology within every aspect of our lives 
represents an opportunity for creative solutions to prevent or better manage this 
devastating condition. In particular, recent advances in wearable and mobile health 
technologies appear to show promise in measuring and modulating dangerous foot 
pressure and inflammation to extend remission and improve the quality of life for these 
most complex patients. This review paper discusses how harnessing wearables and 
digital technologies may improve the management and optimize prevention of DFUs by 
identifying high-risk patients for triage and timely intervention, personalizing prescription 
of offloading, and improving adherence to protective footwear. While still in their infancy, 
we envisage a future network of skin-worn, jewelry-worn, and implantable sensors that, 
if allowed to effectively communicate with one another and the patient, could 
dramatically impact measuring, personalizing, and managing how we and the patients 




It is estimated that  up to one-third of people with diabetes will develop a diabetic foot 
ulcer (DFU) in their lifetime.1 Failure to heal a DFU is a leading cause of hospitalization, 
amputation, disability and death among people with diabetes 1,2.  Globally, it is 
estimated that 20 million people currently have an active DFU; an additional 130 million 
have a history of DFU or the precursor risk factor diabetic peripheral neuropathy (DPN) 
and are expected to develop a DFU without intervention1.   
Diabetes foot care costs represent the single largest category of excess medical costs 
associated with diabetes. It is estimated that one-third of all diabetes related costs are 
spent on diabetic foot care in the United States, with two thirds of these costs incurred 
in the inpatient settings, constituting a substantial economic burden to society.3,4 
Unfortunately, even after the resolution of a DFU, recurrence is common and estimated 
to be 40% within 1 year, ~60% within 3 years, and 65% within 5 years 1. 
In light of the impending diabetes epidemic and the high prevalence of DFU and its 
recurrence, the need for enhanced prevention of DFUs and/or keeping patients with 
ulcers in “remission”1 is clear. DFU rates can be reduced, but effective management is 
multifaceted and requires constant monitoring from patients, caregivers, and healthcare 
providers1. Thanks to new “smart” sensors, which communicate with a handheld device 
or the cloud, and communication technologies such as smartphones and smart 
connected home infrastructure, new opportunities exist to improve management DFUs, 
as well as aim to prevent their initial occurrence 5. With the help of artificial intelligent 
(AI), patients can be prompted to check their feet, glucose levels, or weight, and enter 
results into mobile patient portals. Even better: they can transmit the results to their 
physicians in real time. These fast-growing, low-cost, and widely available resources 
can help predict one’s risk for foot ulcers, infections, peripheral arterial disease, frailty, 
and other diabetes-associated complications, ultimately saving limbs and lives5.  
In this manuscript some of the recent promising technology developments, which may 
assist not only in terms of improving the management of DFUs but also could assist in 
effective prevention of DFU are discussed. More specifically, recent developments in 
three specific areas have been discussed: 1) technologies to identify high-risk patients 
for triage and timely intervention, 2) technologies for effective and personalized 
prescription of offloading, and 3) technologies to improve adherence to protective 
footwear.  
Technologies to identify high-risk patients for triage and timely intervention  
Ideally, an at-risk diabetic foot should undergo regular podiatry evaluation. However, 
regular visits could easily overload an already overburdened healthcare system. Even in 
specialty diabetes centers with dedicated staff and top-shelf resources, the current 
model of regular visits is still associated with a very high ulcer recurrence rate 6. Thus, 
an improved screening approach is required to facilitate timely referral of those who are 
at the edge of foot ulceration for timely intervention care.  Recent advances in computer 
vision algorithms applied to images of diabetic feet have shown that diabetic foot ulcers 
can be detected automatically with high sensitivity and specificity by artificial intelligence 
technology7-9. This offers the potential for remote triage of patients and enhanced 
monitoring procedures.    
Because inflammation is one of the earliest signs of foot ulceration, technologies that 
capture markers of inflammation may also assist in predicting DFU with sufficient lead 
time for effective intervention 6. Inflammation has five symptoms: dolor (pain), calor 
(heat), rubor (redness), tumor (swelling), and functio laesa (loss of function).  The most 
reliable measurement of inflammation, however,  is based on thermography to measure 
heat, which has been shown to be promising for both prediction and prevention of 
DFU6. The rational for measuring plantar temperature is built on the notion that the skin 
heats up before it breaks down into ulcers. Isolated plantar regions displaying increased 
heat is mainly due to inflammation response of near damaged or damaged tissue and 
originally was suggested by Paul Brand and his team in 1975 as an effective method to 
predict DFU prior skin breakdown10. Almost two decades later in 1997, Armstrong, et al. 
11 have proposed the use of a portable hand-held infrared skin temperature probe as an 
effective technique to predict foot injury as well as foot complications because of 
Charcot's arthropathy. Later on, in 2007, Lavery et al 12 suggested that using 
thermography as a self-assessment tool is effective to prevent recurrence of DFU. 
Despite this evidence and the simplification of thermography using new devices such as 
the FLIR thermal camera (FLIR Systems, Inc. Wilsonville, Oregon, USA)13 , daily plantar 
temperature monitoring is still not part of preventive care for managing the diabetic foot. 
This could be because of compliance issues such as adherence to daily use of 
thermography by the patient or his/her caregivers, the ease of use by non-tech savvy 
patients and caregivers (e.g., some may not be able to follow the instruction to 
accurately assess foot plantar temperature using either app or handheld thermography 
devices), or their ability to interpret the temperature difference (e.g., only the difference 
between two identical spots from left and right feet beyond of approximately 2 degrees 
C is clinically meaningful). To address this gap, Frykberg et al.14 proposed a smart mat 
based on the telehealth concept, which could address the limitations of previous 
thermography tools. Specifically, they studied a novel in-home connected foot mat 
(Podimetrics Mat™, Somerville, MA, USA; Figure 1) to predict prospective incidents of 
DFU and better stratify those who need urgent foot care. This simple-to-use system was 
designed to require no configuration or setup by the users who simply needs to step on 
the mat with both feet for 20 seconds. Using an embedded cellular component the 
collected data are streamed to a cloud, thus there is no need to have WiFi or 
smartphones, which might not be available at the patient’s home. Using an image 
processing tool, an integrated program compares the temperature profile between feet. 
In their study, they demonstrated that a threshold difference of ≥ 2.22 °C between 
corresponding sites on opposite feet correctly predicts 97% of DFU with an average 
lead time of 37 days. Adherence to the mat was high with 86% of participants using the 
mat at least 3 times per week, and an average use of 5 times per week. While this 
accuracy and lead time could be sufficient to better target those who need urgent care, 
the technology suffers from an important limitation: while the 2.22°C threshold provided 
97% sensitivity in Frykberg’s study, it yielded only 43% specificity. Increasing the 
threshold value increases specificity but decreases sensitivity. However, the observed 
high sensitivity and sufficient lead time (37 days) seem to be promising for effective 
triaging and coaching the individual and their caregiver to alter behavior to reduce DFU 
risk. 
There are other wearables and digital health developments for improving daily 
monitoring of plantar temperature and potentially higher sensitivity and specificity to 
predict DFU and extend ulcer-free days in remission. Siren Care (Siren Diabetic Socks, 
Neurofabric, Siren Care Inc., San Francisco, CA; Figure 2)15 is an example of such 
recent developments. It uses smart textiles which allow continuous monitoring of plantar 
temperature and thus may improve specificity for DFU prediction and engage patients to 
reduce risk. But the validity and acceptability of these technologies and their advantage 
compared to a daily single point assessment like that offered by the Podimetrics Mat 
remain to be studied. Similarly, new technologies enable temperature measurements 
between insole and shoe and simultaneous assessment of plantar pressure, 
temperature, and lower extremities joint angles 16. These technologies may assist in 
improvement of triaging those at a high risk of DFU and eventually assist with 
personalized prevention strategies by indirect measurement of shear stress and 
sweating during daily physical activities. However, such developments are in their 
infancy and remain to be examined in prospective and clinical trials.  
 
Technologies for Effective and Personalized Prescription of Offloading: 
The most common pathway to develop a DFU is unchecked repetitive elevated plantar 
mechanical stress (shear or pressure) over time on insensate plantar foot tissue. 
Plantar tissue stress (PTS) is a concept introduced by Lazzarini et al 17 that attempts to 
integrate several well-known mechanical factors into one measure, including plantar 
pressure, shear stress, and daily weight-bearing activity time spent without protected 
footwear (adherence). If PTS remains elevated, then it results in sub-dermal 
inflammation and eventually a DFU. In a sensate foot, patients relieve (offload) the 
inflamed regions aided by feedback from their intact sensory pathways. Unfortunately, 
loss of plantar sensation, or “the gift of pain,” from DPN not only results in the inability to 
perceive elevated levels of PTS, but can also cause gait abnormalities and foot 
deformities that potentially exacerbate PTS 18.   
Management of PTS is essential to mitigating DFU incidence and severity while 
prompting safe mobility in people with high DFU risk. Currently, providers frequently re-
schedule patients for follow-up appointments and guide offloading treatments using their 
clinical intuition of the patient’s average build-up of their pre-ulcerative callus from 
activity and footwear. Over the last 20 years, these clinical judgements have been 
augmented by knowledge from objective laboratory measurements of PTS, 
demonstrating the capacity of various footwear and offloading devices to reduce PTS in 
controlled research settings. More recently, high-quality studies have gone further and 
demonstrated that objective measurements of plantar pressure can be used to 
successfully guide clinical treatment decisions and prolong ulcer-free days for the 
patient in diabetic foot remission 17. This has led to international guidelines 
recommending that clinicians objectively measure plantar pressure to guide the 
prescription of their footwear-related offloading treatments 19-21.  
Although measuring plantar pressure at one moment in time has proven clinically 
beneficial, it is not representative of a person’s entire PTS. A key limitation of the 
current PTS assessment modalities is that they only measure PTS over a short period 
of time which does not factor in daily weight bearing physical activities like walking, 
standing, and sitting while shifting weight to the feet. Currently, a major gap in managing 
DFUs is a lack of understanding about the association between volume of weight-
bearing activity and increased DFU risk. While incorporating a time dimension such as 
measuring pressure time integral (PTI) as a surrogate of cumulative plantar stress 
enables improved detection of those with history of DFU, such measurement still lacks 
specificity to predict DFU formation18. Even prediction of DFU location using plantar 
pressure assessment is uncertain. For example, Veves and colleagues22 reported that 
only 38% of ulcer locations matched the peak pressure location. They also found that 
the peak pressure location actually changed in 59% of patients over the mean follow-up 
time of 30 months. 
To improve the specificity of DFU prediction and personalize prescription of offloading, a 
person’s weight-bearing activity should be considered when measuring PTS17.  Early 
studies investigating weight-bearing activity in patients with DPN were dependent on 
participant’s self-reporting this outcome.  Such self-reporting suffers from both 
intentional (e.g., being afraid for potential consequence of carelessness) and 
unintentional (e.g., forgetting) errors. With advances in signal processing and multi-
sensor devices, it is now possible to comprehensively monitor activity beyond counting 
steps. This includes measurements of total weight-bearing activity, bouts of weight-
bearing activity, and activity intensity23-25 . Najafi et al. 26found that neuropathic patients 
spent approximately three fold as much time weight-bearing per day as walking, and 
that daily standing time may be predictive of worse DFU healing outcomes 27.  In a 
recent exploratory study28, they revealed that walking more than 3000 steps per day 
lowers the rate of wound healing irrespective of type of offloading (i.e., removable and 
irremovable). These recent studies suggest the importance of understanding and 
managing the dosage of weight-bearing activity for both prevention and healing of DFU.  
 Thanks to advances in smart phones, mobile applications, and smart wearable 
sensors, the ability to continuously and simultaneously measure multiple mechanical 
factors comprising PTS has become more achievable. Smart flexible sensors implanted 
in insoles or socks combined with digital health apps have paved the way for monitoring 
PTS during activities of daily living. In 2017, Raviglione et al. 29 proposed the concept of 
daily monitoring of plantar pressure in people at risk of DFU using a smart textile 
(Sensoria socks, Sensoria Inc., Redmond, WA, USA; Figure 3). Their system contained 
a textile pressure sensor attached to a stretchable band, hardware that collects data 
and transmits them via Bluetooth to a smartphone, an app that gathers the data and 
stores them in the cloud, and a web dashboard that displays the data to the clinician. 
They concluded that this technology could determine optimal off-loading in the 
community setting and assist with DFU prevention. However, their study was limited to 
a proof-of-concept design and no clinical study was conducted to support the 
conclusion. Other digital health products available in the market exist to facilitate home 
monitoring of plantar pressure and gait. For example, FeetMe (FeetMe, Paris, France) 
uses a smartphone to monitor high plantar pressure. Surresense Rx®  (Orpyx®, 
Calgary, Canada) uses smartwatch to monitor and notifies sustained plantar pressure 
(pressure above 30-50mmHg lasting for longer than 15 minutes) during activities of 
daily living. The same company designed Orpyx LogR™ that uses a smartphone to 
monitor and remotely visualize (via cloud) in-shoe plantar pressure with an autonomy 
lasting approximately 8-12 hours of active use. However, the clinical validation of these 
products and their ability to prevent DFU via daily plantar pressure screening are still 
unclear. 
 
Technologies to improve adherence to protected footwear 
Clinical care for management of DFUs and extend ulcer-free days in remission focuses 
on external offloading of the foot or shifting plantar pressure during gait from at risk area 
(e.g., the area with high plantar pressure or prior presence of wound) to a low risk area. 
However, clinical footwear trials are equivocal and approximately 40% of these patients 
still re-ulcerate within one year1. A lack of adequate adherence to prescribed footwear is 
the key factor often leading to the majority of these re-ulcerations. Specifically, despite 
taking over 50% of their steps at home, patients view their home as “safe zone” where 
they do not feel the need to wear their prescribed footwear30. As a result, high-risk 
patients wear their prescribed footwear only 15 - 28% of the time. Advances in 
technology now allows us to implement timely alerts, notifications, or auto-reminder 
programs to improve patient adherence.  
Some technologies have been recently designed that enable objective monitoring of 
adherence to footwear. Orthotimer sensor (Rollerwerk, Balingen, Germany)31 is an 
example of such technologies, which is using a microsensor and a unique individual ID 
number. The sensor could be integrated in shoes, insoles, orthotic devices, and 
offloading and enables wear time to be measured.  Using a reading device the wear 
time could be wirelessly read and transferred to a software for wear time analysis. While 
such assessment could be beneficial for educational purpose and potentially improving 
adherence, it lacks an adherence reinforcement component to effectively engage 
patients and their caregivers on daily basis. 
Thanks to advances in digital health, development of smart wearables capable of real-
time notifying harmful plantar pressure throughout the day are now becoming a reality. 
Such development may also have the possibility to engage neuropathic patients to be 
part of their routine daily foot care and change their attitude toward using protected 
footwear and safe mobility. In 2017, Najafi et al.32 tested effectiveness of a real-time 
alerting system (using smartwatch) to improve adherence to prescribed diabetic shoes 
over time. Participants were asked to wear on daily basis a pair of diabetic shoes 
equipment with a thin (< 0.5 mm) smart insole system, (the SurroSense Rx, Orpyx 
Medical Technologies Inc., Calgary, Canada; Figure 4) over a 3-month period. This 
device cues offloading by providing simple instructions via smartwatch (e.g., walk few 
steps after prolonged sitting or standing, check inside of shoes for a foreign object 
causing high pressure, check formation of callus, etc) to manage unprotected sustained 
plantar pressures in an effort to prevent foot ulceration; a successful response to an 
alert was defined as pressure offloading, which occurred within 20 minutes of the alert 
onset. Patient adherence, defined as daily hours of device wear, was determined using 
sensor data and patient questionnaires. They concluded that a real-time and 
comprehensive foot pressure alert method with a minimum number of alerts (one every 
two hours) are effective to allow optimal response to offloading cues from a smart insole 
system and for improving adherence to prescribed diabetic shoes over time. This could 
be explained by the fact that a real-time alert about comprehensive harmful weight-
bearing physical activities (activities such as prolonged bout of standing that may 
occlude capillary bed perfusion in the soft tissues of the foot for significant period of time 
and potentially damage the tissue or leading to local ischemia 32), may assist in 
improving perception of benefit of the technology, which in turn could improve the 
attitude toward using the protected footwear.  
Some researchers have also proposed the use of smartwatches and smartphones to 
engage patients in wearing their offloading device. PAMTag (Figure 5) is one of these 
technologies introduced by Najafi et al.33 to improve adherence to offloading. The 
platform includes a smartwatch and a smart tag named PAMTag, which is attached to 
an offloading device. The PAMTag includes an accelerometer to monitor activity, a 
Radio-Frequency-Identification (RFID) tag, and a radio-frequency (RF) component. The 
smartwatch is programmed to monitor weight bearing activities. In the case of any 
detected weight bearing activities (e.g., standing and walking) the smartwatch 
communicates with the PAMTag. If PAMTag is not in close proximity and/or does not 
confirm the offloading device was worn during those activities, a notification is provided 
to the patient via the smartwatch and text message is sent to a patient’s caregiver to 
encourage use of the offloading device. In addition, the platform enables reporting daily 
adherence to offloading to care providers. The validity of this platform to improve 
adherence to offloading is however unclear. 
 
Conclusion 
In summary, lower extremity complications of diabetes remain all too common. Next-
generation technologies should be geared to the long-term monitoring of people both 
with tissue loss and after healing in remission. This will likely consist of a multitude of 
epidermal, wearable, and implantable sensors. Creating unified methods of 
communicating and assessing these technologies that transcends the proprietary nature 
of individual devices will be critical to the long-term success in helping people remain 
active while optimizing DFU management and supporting DFU prevention strategies. 
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Figure legends  
 
Figure 1: In a prospective cohort observational study of patients in foot ulcer remission, 
Frykberg et al. 14demonstrated that 20 seconds of daily monitoring plantar temperature 
using a smart mat (Podimetrics LLC, MA, USA) and an asymmetry temperature of 
greater than 2.22 oC enables predicting incident of ulcer recurrence with 97% accuracy 
and an average lead time of 37±18 days (mean ± standard deviation). In this study, 129 
eligible subjects were recruited and followed for up to 34 weeks leading to 53 incidents 
of DFU. Then using a machine learning model, an optimum threshold of 2.22 oC was 
identified to yield a tradeoff between longest lead time and detection with highest 
accuracy. This figure is built based results reported by Frykberg et al. study14.  
Figure 2: Siren Socks enables continuous home temperature monitoring, which may be 
used as an early warning system, to provide people with objective feedback so they can 
modify their activity and protect their foot before ulcers develop. This figure is built 
based on the images shared by Siren Care. 
Figure 3: Sensoria Socks (Sensoria Fitness Inc., Redmond, WA, USA) monitor plantar 
pressure under three plantar regions of interest including heel, 1st metatarsal head, and 
5th metatarsal head. They include an anklet that snap to socks’ sensors for transmitting 
data. Via a mobile application, plantar pressure under regions of interest could be 
visualized in real-time. This figure is built based on the images shared by Sensoria 
Fitness Inc. 
Figure 4: Recent advances in wearables enable providing timely and real-time 
feedback to patients to protect their feet against conditions that may increase risk of a 
diabetic foot ulcer. The SurroSense Rx (Orpyx Medical Technologies Inc., Calgary, 
Canada) is an example of technologies that enable continuous screening plantar 
pressure through smart insoles and notify the patient via the smartwatch in form of 
visual, vibratory, and audio feedback in case of a sustained plantar pressure beyond a 
pre-defined threshold. This technology could be used to educate patients to avoid 
conditions leading to sustained plantar pressure (e.g., unbroken and prolonged 
standing), which in turn could assist with prevention of diabetic foot ulcers. A recent 
study by Najafi et al study 32 has also demonstrated the benefit of real-time feedback to 
improve adherence to footwear. This figure is built based on results reported by Najafi 
et al study 32 
Figure 5: PAMTag introduced by Najafi et al. and commercialized by Biosensics LLC to 
engage patients in wearing their offloading devices. This figure is built based on images 
shared by Najafi’s research group.  
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